Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling.
Rockett RJ, Arnott A, Lam C, Sadsad R, Timms V, Gray KA, Eden JS, Chang S, Gall M, Draper J, Sim EM, Bachmann NL, Carter I, Basile K, Byun R, O'Sullivan MV, Chen SC, Maddocks S, Sorrell TC, Dwyer DE, Holmes EC, Kok J, Prokopenko M, Sintchenko V. Rockett RJ, et al. Nat Med. 2020 Sep;26(9):1398-1404. doi: 10.1038/s41591-020-1000-7. Epub 2020 Jul 9. Nat Med. 2020. PMID: 32647358
An emergent clade of SARS-CoV-2 linked to returned travellers from Iran.
Eden JS, Rockett R, Carter I, Rahman H, de Ligt J, Hadfield J, Storey M, Ren X, Tulloch R, Basile K, Wells J, Byun R, Gilroy N, O'Sullivan MV, Sintchenko V, Chen SC, Maddocks S, Sorrell TC, Holmes EC, Dwyer DE, Kok J; 2019-nCoV Study Group. Eden JS, et al. Virus Evol. 2020 Apr 10;6(1):veaa027. doi: 10.1093/ve/veaa027. eCollection 2020 Jan. Virus Evol. 2020. PMID: 32296544 Free PMC article.
Interpret with caution: An evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus.
Rahman H, Carter I, Basile K, Donovan L, Kumar S, Tran T, Ko D, Alderson S, Sivaruban T, Eden JS, Rockett R, O'Sullivan MV, Sintchenko V, Chen SC, Maddocks S, Dwyer DE, Kok J. Rahman H, et al. J Clin Virol. 2020 Jun;127:104374. doi: 10.1016/j.jcv.2020.104374. Epub 2020 Apr 20. J Clin Virol. 2020. PMID: 32361322 Free PMC article.
The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial.
Denholm JT, Davis J, Paterson D, Roberts J, Morpeth S, Snelling T, Zentner D, Rees M, O'Sullivan M, Price D, Bowen A, Tong SYC; ASCOT Investigator Group. Denholm JT, et al. Trials. 2020 Jul 14;21(1):646. doi: 10.1186/s13063-020-04576-9. Trials. 2020. PMID: 32665040 Free PMC article.
Response.
Basile K, Rahman H, Carter I, Donovan L, Kumar S, Tran T, Ko D, Alderson S, Sivaruban T, Eden JS, Rockett R, O'Sullivan MV, Sintchenko V, Chen SC, Maddocks S, Dwyer DE, Kok J. Basile K, et al. J Clin Virol. 2020 Sep;130:104484. doi: 10.1016/j.jcv.2020.104484. Epub 2020 Jun 5. J Clin Virol. 2020. PMID: 32777760 Free PMC article. No abstract available.
The Antibody Response to SARS-CoV-2 Infection.
Hueston L, Kok J, Guibone A, McDonald D, Hone G, Goodwin J, Carter I, Basile K, Sandaradura I, Maddocks S, Sintchenko V, Gilroy N, Chen S, Dwyer DE, O'Sullivan MVN. Hueston L, et al. Open Forum Infect Dis. 2020 Aug 27;7(9):ofaa387. doi: 10.1093/ofid/ofaa387. eCollection 2020 Sep. Open Forum Infect Dis. 2020. PMID: 32989419 Free PMC article.
82 results